Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PCSK1N mRNA | affects expression | 16483693
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PCSK1N mRNA | affects cotreatment|decreases expression | 20360939
|
D003024 |
Clozapine |
Clozapine affects the expression of PCSK1N mRNA | affects expression | 14647396
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PCSK1N mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PCSK1N mRNA | affects cotreatment|decreases expression | 20360939
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of PCSK1N mRNA | increases expression | 14647396
|
D009020 |
Morphine |
Morphine results in increased expression of PCSK1N mRNA | increases expression | 20144693
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of PCSK1N mRNA | decreases expression | 12102619
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PCSK1N mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.77 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.96 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.18 | 17162532 16434500 18056438 19061943 19052882 17620307 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.31 | 12649775 14617031 16160616 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.34 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.34 | 18775368 18985861 20603192 18316065 18396377 17157402 19232924 17688650 18940202 17507914 18177632 15238991 19460635 18558336 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.52 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
5.43 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.21 | 17474063 |
MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.86 | 16288022 18210153 20512989 19335982 17978847 19107877 19171122 19383236 20214788 19519916 20727157 17761372 19208518 20007298 16569478 3581430 17138121 20084675 19701751 20524982 20514400 20432363 16878318 18494052 17055752 17428255 18978308 18691550 16830150 16681979 19919837 18056438 17173139 18971187 16502159 21159647 16698587 10737359 18788625 18665156 10672840 11831363 16935385 18785209 16540662 18393292 18506893 16779866 19539802 19394651 3084413 19418558 16328049 20935162 19822196 20101231 19052882 16807293 17162532 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.19 | 15215559 1977408 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.06 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.06 | 17174075 7505956 2727394 21159647 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.87 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.22 | 17123785 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.06 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.78 | 11575062 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.84 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.84 | 20387270 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.75 | 2540324 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.87 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.13 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.13 | 1733752 19641884 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.33 | 16402076 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.44 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
14.36 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.36 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.40 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
5.51 | 11284996 11554966 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.19 | 16046005 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.16 | 10903974 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.47 | 18785209 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.78 | 10783313 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.66 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.66 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.90 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.12 | 16766008 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.10 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.93 | 20032147 19638242 18407596 18665156 18522880 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.14 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.30 | 19254457 21071580 21278145 20492335 19294768 16942905 18977376 19256749 19690152 20118626 18644402 18754104 19499222 20452335 20101389 9163691 19638242 18978307 20434301 20405173 20137499 15885732 20583210 19833225 19255062 19090486 19426721 21047994 18648771 19073162 12112319 19551842 19996281 2862719 12771043 19427195 21167192 2422723 15175105 19812893 19850985 10737359 20501860 19642983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.75 | 18775883 17174075 19539802 17942915 19009564 21159647 18308698 18093689 16842330 19126423 18282651 18164116 17854601 18253720 16267830 3124819 18079962 19004024 18544905 19519916 2563599 9362446 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.58 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 20970405 21163286 20512841 6695378 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
9.33 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
9.33 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.58 | 19142101 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.95 | 3537620 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
5.36 | 14659530 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
3.85 | 14729435 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.64 | 9029167 3581430 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.51 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.44 | 20387270 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.06 | 19142110 18515891 |
MESH:D010146 |
Pain |
|
Morphine |
4.35 | 20225289 15215642 18699797 16273134 6776300 15275824 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.48 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.56 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.56 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.11 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.21 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.64 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.64 | 11575062 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
4.22 | 19211983 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
5.88 | 19369910 20521326 16141801 11763009 20168265 20452607 17123785 18806925 17667964 17726453 20580759 20107430 18855531 20521320 11151749 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.88 | 19369910 20107430 18513383 1830565 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
5.88 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.87 | 3137016 17978042 1511512 16876388 11044598 15475178 14763951 11738929 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.94 | 20210726 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.14 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.65 | 16141801 20107430 16402076 17502770 20521320 20564506 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.36 | 17933447 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |